1. Analysis of Gastrointestinal and Hepatic Chronic Grant-versus-Host Disease Manifestations on Major Outcomes: A Chronic Grant-versus-Host Disease Consortium Study 
Joseph Pidala, Xiaoyu Chai, Brenda F. Kurland, Yoshihiro Inamoto, Mary E.D. Flowers, Jeanne Palmer, Nandita Khera, Madan Jagasia, Corey Cutler, Mukta Arora, Georgia Vogelsang, Stephanie J. Lee 
Biology of Blood and Marrow Transplantation 
Volume 19, Issue 5, Pages (May 2013)
DOI: /j.bbmt
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Site of GI (A) and hepatic (B) involvement in study population at cohort enrollment. GI involvement defined by score >0 on 0 to 3 NIH scale from clinician survey. Hepatic involvement defined by greater than upper limit of normal reference range according to cohort site-specific reference ranges (8 missing data).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Overall survival and nonrelapse mortality stratified by bilirubin and lower GI involvement at enrollment. (A) Overall survival in months from cohort enrollment, stratified by bilirubin level. (B) Non-relapse mortality in months from cohort enrollment, stratified by bilirubin level. (C) Overall survival in months from cohort enrollment, stratified by lower GI involvement. (D) Non-relapse mortality in months from cohort enrollment, stratified by lower GI involvement.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions